Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan
- PMID: 18617372
- PMCID: PMC7127075
- DOI: 10.1016/j.ijantimicag.2008.04.011
Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan
Abstract
The number of patients presenting to the Emergency Department (ED) with meticillin-resistant Staphylococcus aureus (MRSA) is increasing, but few studies focus on patients with bacteraemia. From January 2001 to June 2006 the clinical characteristics and outcome of 177 consecutive patients with MRSA bacteraemia visiting an ED of a university hospital were studied. The average age of the patients was 65.8 years. Healthcare-associated MRSA bacteraemia comprised 76.3% of all cases. Catheter-related bacteraemia was the most common type of infection (22.6%), followed by soft tissue infection (20.9%) and primary bacteraemia (15.3%). Different types of infection were significantly related to different outcome. In-hospital mortality was 33.3%, but the mortality decreased to 17.7% when patients with rapidly fatal disease and mortality within 3 days were excluded. All isolates exhibited lower susceptibility to vancomycin (minimum inhibitory concentration (MIC) 1-2microg/mL). Factors associated with mortality included severity of underlying illness, severity of bacteraemia and persistent bacteraemia. A detrimental effect of elevated MIC could not be demonstrated despite applying several definitions of patient outcome. Patients admitted to the ED with MRSA bacteraemia carry high overall mortality; however, the severity of underlying illness, severity of bacteraemia and persistent bacteraemia are correlated with mortality, but not vancomycin MICs (2microg/mL) of MRSA isolates.
Figures
Similar articles
-
Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.J Antimicrob Chemother. 2010 Aug;65(8):1792-8. doi: 10.1093/jac/dkq188. Epub 2010 May 28. J Antimicrob Chemother. 2010. PMID: 20511366
-
More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.Int J Antimicrob Agents. 2015 Nov;46(5):532-7. doi: 10.1016/j.ijantimicag.2015.07.013. Epub 2015 Aug 31. Int J Antimicrob Agents. 2015. PMID: 26364848
-
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26. Int J Antimicrob Agents. 2012. PMID: 22633565
-
Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.J Antimicrob Chemother. 2010 Dec;65(12):2658-65. doi: 10.1093/jac/dkq373. Epub 2010 Oct 14. J Antimicrob Chemother. 2010. PMID: 20947620 Review.
-
Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).Int J Antimicrob Agents. 2013 Jun;42 Suppl:S17-21. doi: 10.1016/j.ijantimicag.2013.04.006. Epub 2013 May 8. Int J Antimicrob Agents. 2013. PMID: 23664580 Review.
Cited by
-
Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes.Clin Infect Dis. 2020 Feb 3;70(4):566-573. doi: 10.1093/cid/ciz257. Clin Infect Dis. 2020. PMID: 30949675 Free PMC article.
-
Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01902-17. doi: 10.1128/AAC.01902-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29203479 Free PMC article.
-
Convergent Evolution of Antibiotic Tolerance in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia.Infect Immun. 2022 Apr 21;90(4):e0000122. doi: 10.1128/iai.00001-22. Epub 2022 Mar 14. Infect Immun. 2022. PMID: 35285704 Free PMC article.
-
Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.Antimicrob Agents Chemother. 2014;58(1):317-24. doi: 10.1128/AAC.00520-13. Epub 2013 Oct 28. Antimicrob Agents Chemother. 2014. PMID: 24165181 Free PMC article.
-
The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis.BMC Res Notes. 2016 Sep 29;9(1):455. doi: 10.1186/s13104-016-2252-7. BMC Res Notes. 2016. PMID: 27686168 Free PMC article.
References
-
- Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674. - PubMed
-
- Viallon A., Marjollet O., Berthelot P., Carricajo A., Guyomarc’h S., Robert F. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED. Am J Emerg Med. 2007;25:880–886. - PubMed
-
- Liao C.H., Chen S.Y., Chang S.C., Hsueh P.R., Hung C.C., Chen Y.C. Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital. Diagn Microbiol Infect Dis. 2005;53:85–92. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical